1.16
1.75%
+0.02
Co-Diagnostics Inc stock is currently priced at $1.16, with a 24-hour trading volume of 216.55K.
It has seen a +1.75% increased in the last 24 hours and a +9.43% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.14 pivot point. If it approaches the $1.16 resistance level, significant changes may occur.
Co-Diagnostics Inc Stock (CODX) Financials Data
Co-Diagnostics Inc (CODX) Revenue 2024
CODX reported a revenue (TTM) of $4.66 million for the quarter ending September 30, 2023, a -91.25% decline year-over-year.
Co-Diagnostics Inc (CODX) Net Income 2024
CODX net income (TTM) was -$42.56 million for the quarter ending September 30, 2023, a -380.65% decrease year-over-year.
Co-Diagnostics Inc (CODX) Cash Flow 2024
CODX recorded a free cash flow (TTM) of -$22.51 million for the quarter ending September 30, 2023, a -258.49% decrease year-over-year.
Co-Diagnostics Inc (CODX) Earnings per Share 2024
CODX earnings per share (TTM) was -$1.40 for the quarter ending September 30, 2023, a -397.87% decline year-over-year.
Co-Diagnostics Inc Stock (CODX) Latest News
About Co-Diagnostics Inc
Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.
Cap:
|
Volume (24h):